SCYNEXIS Stock

SCYNEXIS ROIC

The Return on Invested Capital (ROIC) of SCYNEXIS (SCYX) as of Jul 19, 2026 is -30.96 %. In the previous year, Return on Invested Capital (ROIC) was 78.76 % — a change of -139.31% (lower).

ROIC

-30.96 %

YoY

-139.31%

Last updated:

Return on Invested Capital (ROIC) of SCYNEXIS is 2026 -30.96 % . Return on Invested Capital (ROIC) of SCYNEXIS was 2025 78.76 % . It decreases by -139.31% lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Return on Invested Capital (ROIC) of SCYNEXIS is -30.96 % in 2026.

Access this data via the Eulerpool API

Profitability — SCYNEXIS

All Key Metrics — SCYNEXIS